These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A system for the high efficiency replication of HIV-1 in neural cells and its application to anti-viral evaluation. Volsky B; Sakai K; Reddy MM; Volsky DJ Virology; 1992 Jan; 186(1):303-8. PubMed ID: 1309276 [TBL] [Abstract][Full Text] [Related]
6. Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin. Han Y; Ventura CL; Black KP; Cummins JE; Hall SD; Jackson S Oral Microbiol Immunol; 2000 Apr; 15(2):82-8. PubMed ID: 11155170 [TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 infection of human placental macrophages in vitro. Kesson AM; Fear WR; Kazazi F; Mathijs JM; Chang J; King NJ; Cunningham AL J Infect Dis; 1993 Sep; 168(3):571-9. PubMed ID: 7689088 [TBL] [Abstract][Full Text] [Related]
8. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences. Li XD; Moore B; Cloyd MW Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547 [TBL] [Abstract][Full Text] [Related]
9. Persistent inapparent HIV-1 infection of human neuroblastoma cells. Vesanen M; Linna T; Vaheri A Arch Virol; 1991; 120(3-4):253-61. PubMed ID: 1958129 [TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus infection of human bone marrow stromal myoid cells. Ercoli L; Sarmati L; Parisi SG; Mancino G; De Santis G; Bonanno E; Spagnoli LG; Rocchi G; Andreoni M Scand J Infect Dis; 1996; 28(4):335-40. PubMed ID: 8893394 [TBL] [Abstract][Full Text] [Related]
11. Direct in vitro infection of human intestine with HIV-1. Fleming SC; Kapembwa MS; MacDonald TT; Griffin GE AIDS; 1992 Oct; 6(10):1099-104. PubMed ID: 1281642 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication. He X; Simoneau CR; Granoff ME; Lunemann S; Dugast AS; Shao Y; Altfeld M; Körner C J Immunol Methods; 2016 Jul; 434():53-60. PubMed ID: 27094484 [TBL] [Abstract][Full Text] [Related]
13. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. McElrath MJ; Pruett JE; Cohn ZA Proc Natl Acad Sci U S A; 1989 Jan; 86(2):675-9. PubMed ID: 2492110 [TBL] [Abstract][Full Text] [Related]
14. Productive HIV-1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin-1 beta plus tumor necrosis factor-alpha. Conaldi PG; Serra C; Dolei A; Basolo F; Falcone V; Mariani G; Speziale P; Toniolo A J Med Virol; 1995 Dec; 47(4):355-63. PubMed ID: 8636703 [TBL] [Abstract][Full Text] [Related]
15. In-vitro infection of peripheral blood dendritic cells with human immunodeficiency virus-1 causes impairment of accessory functions. Chehimi J; Prakash K; Shanmugam V; Jackson SJ; Bandyopadhyay S; Starr SE Adv Exp Med Biol; 1993; 329():521-6. PubMed ID: 8379420 [No Abstract] [Full Text] [Related]
16. Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures. Tschochner M; Schwingel E; Thein C; Wittmann S; Paatz C; Walter H J Virol Methods; 2007 Apr; 141(1):87-96. PubMed ID: 17196267 [TBL] [Abstract][Full Text] [Related]
17. Human erythrocytes bearing electroinserted CD4 neutralize infection in vitro by primary isolates of human immunodeficiency virus type 1. Tosi PF; Schwartz D; Sharma U; Mouneimne Y; Hannig J; Li G; McKinley G; Grieco M; Flexner CW; Lazarte J; Norse D; Nicolau C; Volsky DJ Blood; 1996 Jun; 87(11):4839-44. PubMed ID: 8639857 [TBL] [Abstract][Full Text] [Related]